November 30, 2017
UPCOMING /Recent Talks

Understanding the Medical and Legal Aspects of Surrogacy - An Option in Infertility

with Dr. Aimee Evyazzadeh & Greggory M Field, Esq
December 14th, 2017. 6PM EST RSVP
Surrogacy is a method of assisted reproduction for people who are unable to conceive due to medical complications or any other reason. It is an agreement where a woman agrees to carry a pregnancy for a couple or a person, who will become the baby's parent after birth.  Surrogacy has been a controversial issue around the world and involves a lot of complicated contracts that intended parents as well as surrogates need to abide by. We are discussing the medical and legal aspects of surrogacy with reproductive endocrinologist Dr. Aimee D. Eyvazzadeh, reproductive/fertility lawyer Greggory M Field, and Emily M Field who became a mother through surrogacy.  
Dr. Aimee Eyvazzadeh
Greggory M Field, Esq
Emily Dubin Field
Shweta Mishra
Dr. Carl June's CAR-T Cell Journey and the Cancer Treatment Revolution with Dr. Carl June 
November 15th, 2017. 1PM EST LISTEN
FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms the body's own immune system to recognise and kill cancer cells. The therapy initially called CAR-T cell immunotherapy and now named Kymriah by Novartis, is approved to treat children and young adults with a recurrent form of blood cancer called acute lymphoblastic leukemia (ALL). Dr. Carl June of University of Pennsylvania is one of the pioneers of CAR-T cell research and leads the team responsible for the historic FDA approval. We are discussing Dr. June's CAR-T cell journey to understand the nuances of this therapy. The discussion will also bring to focus the opportunity that these engineered immune cells present to cancer treatment, and their possible use in treatment of other cancers.   
Dr. Carl June
Gary Petersen 
Jack Aiello
Mike Scott
Priya Menon
Demystifying Stem Cell Transplants for Multiple Myeloma Treatment  with Dr. Rafael Fonseca
October 4th, 2017. 5 PM EST LISTEN
In 2017 stem cell transplants remains a key option for treatment of eligible multiple myeloma patients, and in majority of patients it is done as a part of frontline therapy. Research shows that stem cell transplants significantly increase the amount of time, for which a patient has their disease under control. How safe are these transplants? Who is eligible to get one? What are the side effects and how can patients tackle them? The myeloma panel is talking to Dr. Rafael Fonseca for answers to these and more on the latest developments in stem cell transplant technology in multiple myeloma.   

Dr. Rafael Fonseca 
Gary Petersen 
Jack Aiello
Yelak Biru
Priya Menon
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks
TrialX Editor